EQL Pharma was founded in late 2006 by Christer Fåhraeus and Karin Wehlin. The company has from the start been driven with an entrepreneurial spirit, always looking for new ways to develop and improve ourselves. This applies to both our product portfolio and our business model as well as the quality and the individuals in our company. EQL Pharma currently has a handful of niche products on the market with a several-fold larger pipeline of products under development in close cooperation with our partners in Europe, Asia and India.